日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat ,Elena Garralda ,Vladimir Galvao ,Philippe A Cassier ,Carlos Gomez-Roca ,Iphigenie Korakis ,Peter Grell ,Aung Naing ,Patricia LoRusso ,Romana Mikyskova ,Nada Podzimkova ,Milan Reinis ,Kaissa Ouali ,Andreu Schoenenberger ,Joachim Kiemle-Kallee ,Sascha Tillmanns ,Richard Sachse ,Ulrich Moebius ,Radek Spisek ,David Bechard ,Lenka Palova Jelinkova ,Irena Adkins ,Aurelien Marabelle

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat,Elena Garralda,Vladimir Galvao,Philippe A Cassier,Carlos Gomez-Roca,Iphigenie Korakis,Peter Grell,Aung Naing,Patricia LoRusso,Romana Mikyskova,Nada Podzimkova,Milan Reinis,Kaissa Ouali,Andreu Schoenenberger,Joachim Kiemle-Kallee,Sascha Tillmanns,Richard Sachse,Ulrich Moebius,Radek Spisek,David Bechard,Lenka Palova Jelinkova,Irena Adkins,Aurelien Marabelle  0

SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity

SOT101 诱导 NK 细胞毒性并增强抗体依赖性细胞毒性和抗肿瘤活性

Zuzana Antosova, Nada Podzimkova, Jakub Tomala, Katerina Augustynkova, Katerina Sajnerova, Eva Nedvedova, Milada Sirova, Guy de Martynoff, David Bechard, Ulrich Moebius, Marek Kovar, Radek Spisek, Irena Adkins

Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia

儿科重症监护室的肠内营养和抑酸治疗:对呼吸机相关性肺炎风险的影响

Albert, Ben D; Zurakowski, David; Bechard, Lori J; Priebe, Gregory P; Duggan, Christopher P; Heyland, Daren K; Mehta, Nilesh M